President Trump Considers Marijuana Rescheduling to Schedule III, Following 2024 Biden Proposal and Supporting Veterans’ Medical Treatments

President Donald Trump is considering rescheduling marijuana from its current classification under the DEA's Schedule 1 to Schedule 3, a move that would not legalize cannabis federally but could facilitate increased medical research and access to FDA-approved treatments, particularly for veterans dealing with conditions like PTSD. This potential policy shift follows a 2024 proposal by the Biden administration to reclassify marijuana similarly. The rescheduling discussion has drawn attention from various stakeholders, including former presidential drug policy adviser Kevin Sabet, who has urged caution. The debate also highlights ongoing regulatory challenges in states such as Texas regarding hemp-derived THC products. The distinction between rescheduling and decriminalization remains a key point, with proponents emphasizing that the change aims to support medical research rather than broader legalization. The topic was also recently featured in popular culture, with a "South Park" episode depicting a marijuana business owner lobbying President Trump for rescheduling, framing it as mutually beneficial for the cannabis industry and the administration.